RespireRx Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
14.40
162.80
53.20
92.00
84.90
33.30
Total Accounts Receivable
-
48.00
-
-
-
-
Other Current Assets
2.40
24.20
29.10
103.60
91.80
87.80
Total Current Assets
16.70
235.00
82.30
195.70
176.70
121.10
Net Property, Plant & Equipment
-
16.70
12.10
5.20
-
-
Other Assets
35.10
148.60
51.40
33.00
18.10
3.10
Total Assets
51.90
400.30
145.80
233.80
194.80
124.20
ST Debt & Current Portion LT Debt
769.60
449.80
630.60
809.90
756.30
Accounts Payable
-
1,687.90
1,349.40
-
2,922.00
Other Current Liabilities
3,470.70
463.00
1,028.10
4,917.30
871.80
Total Current Liabilities
4,240.30
2,600.70
3,008.10
5,727.20
4,550.20
Total Liabilities
4,240.30
2,600.70
3,008.10
5,727.20
4,550.20
Common Equity (Total)
4,210.10
3,094.80
3,142.50
5,515.10
4,377.10
Total Shareholders' Equity
4,188.40
2,200.40
2,862.20
5,493.40
4,355.40
Total Equity
4,188.40
2,200.40
2,862.20
5,493.40
4,355.40
Liabilities & Shareholders' Equity
51.90
400.30
145.80
233.80
194.80
Preferred Stock (Carrying Value)
21.70
894.40
280.30
21.70
21.70
About RespireRx Pharmaceuticals
View Profile
